BASI Financial Facts

General and administrative: 1.16M
Diluted net income (loss) per share: 0.02
See Full Income Statement

Total liabilities and shareholders' equity: 24.86M
Goodwill: 1.38M
See Full Balance Sheet

Bioanalytical Systems (BASI) Earnings

  |   Expand Research on BASI
Next EPS Date 12/24/14 *Est. EPS Growth Rate -71.4% *Last Qtr.
Average EPS % Beat Rate -125.0% Revenue Growth Rate +7.7% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/14/14 Q314 $0.02N/A N/A $6.03M$5.6M N/A Details
5/15/14 Q214 -$0.03N/A N/A $5.91M$5.16M N/A Details
2/13/14 Q114 $0.04N/A N/A $6.22M$5.8M N/A Details
12/24/13 Q413 $0.03N/A N/A $5.51M$6.54M N/A Details
10/18/13 Q313 $0.07$0.01 +$0.06$5.6M$5.65M N/A Details
5/15/13 Q213 -$0.02$0.01 -$0.03$5.16M$5.74M N/A Details
2/14/13 Q113 $0.02-$0.03 +$0.05$5.8M$6.65M N/A Details
12/27/12 Q412 -$0.32-$0.03 -$0.29$6.54M$7.07M N/A Details